117 related articles for article (PubMed ID: 10714509)
21. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
Hartmann RW; Schwarz W; Heindl A; Schönenberger H
J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
[TBL] [Abstract][Full Text] [Related]
22. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols.
Hartmann RW; Heindl A; Schönenberger H
J Med Chem; 1984 May; 27(5):577-85. PubMed ID: 6325689
[TBL] [Abstract][Full Text] [Related]
23. Antimycobacterial activity of 1-substituted indolizines.
Gundersen LL; Negussie AH; Rise F; ØStby OB
Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
[TBL] [Abstract][Full Text] [Related]
24. delta9-Tetrahydrocannabinol and 17beta-estradiol bind to different macromolecules in estrogen target tissues.
Okey AB; Bondy GP
Science; 1978 Apr; 200(4339):312-4. PubMed ID: 635586
[TBL] [Abstract][Full Text] [Related]
25. A reinvestigation of 4-hydroxyindole-6-carboxylate synthesis from pyrrole-2-carboxaldehyde: a facile synthesis of indoles and indolizines.
Kim M; Vedejs E
J Org Chem; 2004 Oct; 69(20):6945-8. PubMed ID: 15387633
[TBL] [Abstract][Full Text] [Related]
26. [Properties of alkylating derivatives of estrogens].
Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.
Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F
Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696
[TBL] [Abstract][Full Text] [Related]
29. [Estradiol derivatives: relationship between uterotrophic activity and affinity to the cytosol receptor].
Tang ZM; Chen MY; Zhang Q
Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):186-91. PubMed ID: 6228119
[No Abstract] [Full Text] [Related]
30. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
31. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
32. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
Filla SA; Mathes BM; Johnson KW; Phebus LA; Cohen ML; Nelson DL; Zgombick JM; Erickson JA; Schenck KW; Wainscott DB; Branchek TA; Schaus JM
J Med Chem; 2003 Jul; 46(14):3060-71. PubMed ID: 12825944
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory activities of indolizine derivatives: a patent review.
Dawood KM; Abbas AA
Expert Opin Ther Pat; 2020 Sep; 30(9):695-714. PubMed ID: 32684068
[TBL] [Abstract][Full Text] [Related]
34. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
Elliston JF; Zablocki JA; Katzenellenbogen BS; Katzenellenbogen JA
Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor in human myoma tissue.
Puukka MJ; Kontula KK; Kauppila AJ; Janne OA; Vihko RK
Mol Cell Endocrinol; 1976 Nov; 6(1):35-44. PubMed ID: 1001806
[TBL] [Abstract][Full Text] [Related]
37. A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines.
Gupta SP; Mathur AN; Nagappa AN; Kumar D; Kumaran S
Eur J Med Chem; 2003 Oct; 38(10):867-73. PubMed ID: 14575933
[TBL] [Abstract][Full Text] [Related]
38. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII
Olaru AM; Vasilache V; Danac R; Mangalagiu II
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1291-1298. PubMed ID: 29072097
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.
Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S
Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120
[TBL] [Abstract][Full Text] [Related]
40. Understanding the Action of Indolizines as Biologically Active Moieties: A Molecular Dynamics Study.
Szefler B; Czelen P; Diudea MV
Curr Comput Aided Drug Des; 2017; 13(1):22-29. PubMed ID: 27719631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
